2.1 Multi-sector and One Health collaboration/coordination

2.3 Country progress with development of a national action plan on AMR

2.3 Status of current national action plan on AMR

2.3A Country progress with development of a national action plan on AMR

2.4.1 [Human Health] Sectors and/or sub-sectors addressed in the national action plan on AMR or any other national reponse to AMR

2.4.2 [Terrestrial Animal Health/ food-producing animals] Sectors and/or sub-sectors addressed in the national action plan on AMR or any other national reponse to AMR

2.4.3 [Terrestrial Animal Health / companion animals] Sectors and/or sub-sectors addressed in the national action plan on AMR or any other national reponse to AMR

2.4.4 [Aquatic Animal Health] Sectors and/or sub-sectors addressed in the national action plan on AMR or any other national reponse to AMR

2.4.5 [Plant Health] Sectors and/or sub-sectors addressed in the national action plan on AMR or any other national reponse to AMR

2.4.6 [Food Production] Which sectors and/or sub-sectors are addressed in the national action plan on AMR or any other national reponse to AMR

2.4.7 [Food Safety] Sectors and/or sub-sectors addressed in the national action plan on AMR or any other national reponse to AMR

2.4.8 [Environment] Sectors and/or sub-sectors addressed in the national action plan on AMR or any other national reponse to AMR

2.4.b Does the multisector coordination mechanism review current and previous year data from TrACSS as a way to monitor progress of AMR national action plan implementation?

2.5.1 [Civil society organizations] Stakeholders are actively involved in the development, implementation and monitoring of the national action plan on AMR

2.5.2 [Local communities] Stakeholders are actively involved in the development, implementation and monitoring of the national action plan on AMR

2.5.3 [Academia] Stakeholders are actively involved in the development, implementation and monitoring of the national action plan on AMR

2.5.4 [Professional associations (health, agriculture, veterinary, environment)] Stakeholders are actively involved in the development, implementation and monitoring of the national action plan on AMR

2.5.5 [Private sector] Stakeholders are actively involved in the development, implementation and monitoring of the national action plan on AMR

2.5.6 [UN/ other Inter-governmental organizations] Stakeholders are actively involved in the development, implementation and monitoring of the national action plan on AMR

2.6 Is your country’s national planning on AMR integrated with other existing action plans or, strategies?

2.6.a.1 [Human] Research is included in which sectors in the national action plan on AMR

2.6.a.2 [Animal] Research is included in which sectors in the national action plan on AMR

2.6.a.3 [Plant] Research is included in which sectors in the national action plan on AMR

2.6.a.4 [Environment] Research is included in which sectors in the national action plan on AMR

2.6.a.5 [Multisectoral/One Health] Research is included in which sectors in the national action plan on AMR

2.7 Investment/economic case for implementing the national action plan on AMR to support resource mobilization (domestic and external funding) and advocacy

2.8.2 Country has laws or regulations on prescription and sale of antimicrobials for terrestrial animal use.

2.8.3 Country has laws or regulations on prescription and sale of antimicrobials for aquatic animals.

2.8.5 Country has laws or regulations that prohibits the use of antibiotics for growth promotion in terrestrial animals in the absence of risk analysis.

2.8.6 Country has legislation on the registration and use of applicable pesticides with antimicrobial effects, such as bactericides and fungicides used in plant production.

2.10 Youth education and AMR

2.11 Is the country using relevant antimicrobial consumption/use data to inform operational decision making and amend policies?

2.11.4 [National immunization strategy for human health] Integration of national planning on AMR with other existing action plans or, strategies

2.12 Country has laws or regulations on prescription and sale of antimicrobials, for human use.

2.12 Is the country using relevant antimicrobial resistance surveillance data to inform operational decision making and amend policies

2.13 Laws or regulations that prohibit the use and sale of substandard and falsified medicines for human health

2.19 Legislation on waste management to prevent and reduce the emergence and spread of AMR and antimicrobial residues in the environment. 

2.21 Evidence-based behaviour change strategies in national action plan on AMR.

2.22 Country capacity to support evidence-based behaviour change strategies.

2.23 Raising awareness and understanding of AMR risks and response.

2.26 Involvement of ministry of education in the implementation of the national action plan on AMR, such as awareness raising, capacity building, curriculum improvement and/or pre-service training on AMR

2.29 Has the country established or starting the implementation of an Integrated Surveillance System for Antimicrobial Resistance

2.29.1.1 [Human Health] Sectors involved in the implementation of an Integrated Surveillance System for Antimicrobial Resistance?

2.29.1.2 [ Terrestrial animal health ] Sectors involved in the implementation of an Integrated Surveillance System for Antimicrobial Resistance?

2.29.1.3 [Aquatic animal health] Sectors involved in the implementation of an Integrated Surveillance System for Antimicrobial Resistance?

2.29.1.4 [Plant health] Sectors involved in the implementation of an Integrated Surveillance System for Antimicrobial Resistance?

2.29.1.5 [Food production] Sectors involved in the implementation of an Integrated Surveillance System for Antimicrobial Resistance?

2.29.1.6 [Food safety] Sectors involved in the implementation of an Integrated Surveillance System for Antimicrobial Resistance?

2.29.1.7 [Environment] Sectors involved in the implementation of an Integrated Surveillance System for Antimicrobial Resistance?

3.1 Training and professional education on AMR in the human health sector

3.2 National monitoring system for consumption and rational use of antimicrobials in human health

3.2 National system for national antimicrobial use in humans

3.3 Monitoring system for facility-level / hospital antimicrobial use in human health

3.4 National monitoring and reporting system for substandard and falsified antimicrobials in humans

3.4.2b Capacity to perform AST for critically important bacteria.

3.4.3b Capacity to perform AST for critically important fungi.

3.4.5b Continuity of services for clinical bacteriology labs - mechanism to report stockouts.

3.5 National surveillance system for antimicrobial resistance (AMR) in humans

3.7b Capacity to perform AST for critically important bacteria

3.10b Continuity of services for clinical bacteriology laboratories

3.14 Infection Prevention and Control (IPC) in human health care

3.15 Optimizing antimicrobial use in hospitals

3.16 Optimizing antimicrobial use in primary care

3.17 Adoption of “AWaRe” classification of antibiotics in the National Essential Medicines List

9.1 Optimizing antimicrobial use in human health

4.2 Training and professional education on AMR in the aquatic animal health sector

4.3 Progress with strengthening veterinary services

4.4 Progress with strengthening aquatic animal health services

4.7 National surveillance system for antimicrobial resistance (AMR) in live terrestrial animals

4.8 National surveillance system for antimicrobial resistance (AMR) in live aquatic animals

4.9 Biosecurity and good animal husbandry practices to reduce the use of antimicrobials and minimize development and transmission of AMR in terrestrial animal production

4.10 Biosecurity and good animal husbandry practices to reduce the use of antimicrobials and minimize development and transmission of AMR in aquatic animal production

4.11 Optimizing antimicrobial use in terrestrial animal health

4.12 Optimizing antimicrobial use in aquatic animal health

4.13 Legislation to monitor and address substandard and falsified antimicrobials for animals

4.14 defined vaccination strategy(ies), with an implementation plan

4.15 Antimicrobial stewardship programme in the animal health sector

5.1 Training and professional education on AMR provided to the agriculture (animal and plant), food production, food safety and the environment sectors

5.2 National monitoring system for antimicrobial- pesticide use in plant production including bactericides and fungicides

5.4a National AMR Laboratory network in animal health and food safety sectors - Effective integration of laboratories in the AMR surveillance

5.4b National AMR Laboratory network in animal health and food safety sectors - Level of the standardization and harmonization of procedures among laboratories included in the AMR surveillance system

5.4c National AMR Laboratory network in animal health and food safety sectors - Relevance of diagnostic techniques used by laboratories included in the AMR surveillance system

5.4d National AMR Laboratory network in animal health and food safety sectors - Technical level of data management of the laboratory network in the AMR surveillance system

5.5a National monitoring and surveillance system for AMR in animals and food of animal origin- national plan or system in place for AMR monitoring and surveillance in animals and food for healthy terrestrial animals

5.5b National monitoring and surveillance system for AMR in animals and food of animal origin- national plan or system in place for AMR monitoring and surveillance in animals and food for diseased terrestrial animals

5.5c National monitoring and surveillance system for AMR in animals and food of animal origin-national plan or system in place for AMR monitoring and surveillance in animals and food for healthy aquatic animals

5.5d National monitoring and surveillance system for AMR in animals and food of animal origin- national plan or system in place for AMR monitoring and surveillance in animals and food for diseased aquatic animals

5.5e National monitoring and surveillance system for AMR in animals and food of animal origin-national plan or system in place for AMR monitoring and surveillance in animals and food for food (animal or plant origin)

5.5f No National monitoring and surveillance system for AMR in animals and food of animal origin- national plan or system in place for AMR monitoring and surveillance in animals and food.

5.6 AMR data in animals and food to FAO InFARM system

5.7 Assessment of AMR surveillance systems and laboratory networks in food and agriculture sectors

5.8 Good manufacturing and hygiene practices to reduce the development and transmission of AMR in food processing

5.9 Policies or measures to monitor and reduce the release of antimicrobial-resistant bacteria, genes, and residues into the environment from food and agricultural activities

5.11 National regulation for the manufacture, distribution, and use of antimicrobials in plant health

9.3 Optimizing antimicrobial pesticide such as bactericides and fungicides use in plant production

6.1 Training and professional education on environmental dimensions of antimicrobial resistance (AMR)

6.2 National surveillance system for antimicrobial resistance (AMR) in the environment

6.3 Is there a system for regular monitoring (passive surveillance) of antimicrobial compounds and their metabolites (or residues) and resistant bacteria or antimicrobial resistance genes (ARGs) in water quality

6.3 Initiatives (e.g., regulations, policies, and/or standards) for preventing and reducing the emergence and spread of AMR and antimicrobial residues in wastewater and waste from key sectors, including the pharmaceutical industry, healthcare facilities, animal production, plant production, and municipal/household into the environment

6.4.a Preventive and management initiatives for wastewater to prevent and reduce the discharge of AMR and antimicrobial residues into the environment for pharmaceutical industry

6.4.b Preventive and management initiatives for wastewater to prevent and reduce the discharge of AMR and antimicrobial residues into the environment for healthcare facilities

6.4.c Preventive and management initiatives for wastewater to prevent and reduce the discharge of AMR and antimicrobial residues into the environment for agriculture production

6.4.d Preventive and management initiatives for wastewater to prevent and reduce the discharge of AMR and antimicrobial residues into the environment for plant production

6.4.e Preventive and management initiatives for wastewater to prevent and reduce the discharge of AMR and antimicrobial residues into the environment for municipal/household

6.4.f No preventive and management initiatives for wastewater

6.5.a Preventive and management initiatives for waste to prevent and reduce the discharge of AMR and antimicrobial residues into the environment for pharmaceutical industry

6.5.b Preventive and management initiatives for waste to prevent and reduce the discharge of AMR and antimicrobial residues into the environment for healthcare facilities

6.5.c Preventive and management initiatives for waste to prevent and reduce the discharge of AMR and antimicrobial residues into the environment for agriculture production

6.5.d Preventive and management initiatives for waste to prevent and reduce the discharge of AMR and antimicrobial residues into the environment for for plant production

6.5.e Preventive and management initiatives for waste to prevent and reduce the discharge of AMR and antimicrobial residues into the environment for municipal/household

6.5.f No preventive and management initiatives for waste

6.6 Initiatives (e.g., regulations, guidelines, and/or take-back schemes) for safe disposal of unused antimicrobials from the key sectors, including the pharmaceutical industry, healthcare facilities, animal production, plant production, and municipal/household.

6.7.a Safe disposal of unused antimicrobial initiatives for pharmaceutical industry

6.7.b Safe disposal of unused antimicrobial initiatives for healthcare facilities

6.7.c Safe disposal of unused antimicrobial initiatives for agriculture production

6.7.d Safe disposal of unused antimicrobial initiatives for for plant production

6.7.e Safe disposal of unused antimicrobial initiatives for municipal/household

6.7.f No safe disposal of unused antimicrobial initiatives

10.a Has a national assessment of risks for residues of antimicrobial compounds and antimicrobial resistant pathogens in the environment been conducted?

10.b Country has legislation and/or regulations to prevent contamination of the environment with antimicrobials- antimicrobial compounds and their metabolites discharged to the environment